Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.31 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.31 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23665184 | 0.88 | ADRB2 (0.33) | TSHRALDH1A1MAPK1HIF1AADRB2 | |
| SCHEMBL23902061 | 0.82 | — | — | |
| SCHEMBL9407492 | 0.81 | ADRB2 (0.36) | TSHRALDH1A1MAPK1HIF1AADRB2 | |
| SCHEMBL18934365 | 0.75 | — | — | |
| SCHEMBL23902017 | 0.74 | LMNA (0.33) | TSHRHIF1AADRB2ADRA1A | |
| SCHEMBL23902024 | 0.74 | LMNA (0.33) | TSHRHIF1AADRB2ADRA1A | |
| SCHEMBL23902012 | 0.74 | LMNA (0.33) | TSHRHIF1AADRB2ADRA1A | |
| SCHEMBL91192 | 0.74 | — | — | |
| SCHEMBL104096 | 0.73 | — | — | |
| SCHEMBL15934167 | 0.73 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4239722-A1 | NEGATIVE ELECTRODE ACTIVE MATERIAL, PREPARATION METHOD THEREFOR, AND SECONDARY BATTERY COMPRISING SAME | Contemporary Amperex Technology Co., Limited (CN) | 2023-09-06 | — | — | EP | disclosed |
| EP-4198030-A1 | IMMUNOREGULATORY COMPOUND AND ANTITUMOR APPLICATION THEREOF | Shanghaitech University (CN) | 2023-06-21 | — | — | EP | disclosed |
| US-20210309641-A1 | AMIDINES AND AMIDINE ANALOGS FOR THE TREATMENT OF BACTERIAL INFECTIONS AND POTENTIATION ANTIBIOTICS | GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) | 2021-10-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210309641-A1 | AMIDINES AND AMIDINE ANALOGS FOR THE TREATMENT OF BACTERIAL INFECTIONS AND POTENTIATION ANTIBIOTICS | PAM, AMPD1, AMPD3 | TSHR 1561/4885ALDH1A1 4745/4885MAPK1 1517/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.